Waters launches industry-first reversed-phase bioseparation columns to deliver up to 3x faster GLP-1 characterization and 2x faster LNP component analysis.

{
  "signal_id": "fdc7d4c3-5a8e-44cb-8bb6-2ea9821d38e6",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-06-08T12:00:00+00:00",
  "company": {
    "name": "Waters",
    "domain": "waters.com"
  },
  "data": {
    "url": "https://www.siamnews.net/pr-news/waters-launches-industry-first-reversed-phase-bioseparation-columns-to-deliver-up-to-3x-faster-glp-1-characterization-and-2x-faster-lnp-component-analysis",
    "event": "55th International Symposium on High Performance Liquid Phase Separations and Related Techniques",
    "title": "Waters launches industry-first reversed-phase bioseparation columns to deliver up to 3x faster GLP-1 characterization and 2x faster LNP component analysis.",
    "ticker": "NYSE:WAT",
    "excerpt": "Waters launches industry-first reversed-phase bioseparation columns to deliver up to 3x faster GLP-1 characterization and 2x faster LNP component analysis.\n\n* Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottlenecks.\n* Delivers up to 2x increase in resolving power and sensitivity to identify and track low-level impurities for improved regulatory readiness.\n* Industry-first chemical and physical particle optimization delivers reproducible methods for increasingly complex biologics.\n\nMILFORD, Mass., June 8, 2026 /PRNewswire/ - 55th International Symposium on High Performance Liquid Phase Separations and Related Techniques - Waters Corporation (NYSE: WAT) today announced the launch of the BioResolve(TM) Peptide and GTxResolve(TM) Lipid Phenyl-Hexyl+ and C18+ Columns, a first-of-its-kind reversed-phase (RP) column platform designed to tackle a persistent biopharmaceutical challenge: reliably separating structurally and chemically similar impurities in GLP-1 peptides, insulin, and lipid nanoparticles (LNPs) to support the development of safe, effective drug products.\n\nBioResolve Peptide and GTxResolve Lipid Columns are the first columns Waters has introduced to market specifically QC batch-tested for GLP-1 analysis and lipid nanoparticles, solving a longstanding customer pain...",
    "product": "BioResolve Peptide and GTxResolve Lipid Phenyl-Hexyl+ and C18+ Columns",
    "summary": "Waters Corporation launched BioResolve Peptide and GTxResolve Lipid Phenyl-Hexyl+ and C18+ Columns at 55th International Symposium on High Performance Liquid Phase Separations and Related Techniques on Jun 8th '26.",
    "location": "Milford, Massachusetts, United States, Northern America, Americas",
    "planning": false,
    "image_url": "https://i0.wp.com/mmx.prnasia.com/media/MS636097/Waters_Corporation_Logo.jpg?id=OA2690321&p=medium600&ssl=1",
    "confidence": 0.3321,
    "product_data": {
      "full_text": "BioResolve(TM) Peptide and GTxResolve(TM) Lipid Phenyl-Hexyl+ and C18+ Columns",
      "fuzzy_match": true
    },
    "published_at": "2026-06-08T12:00:00Z",
    "location_data": [
      {
        "city": "Milford",
        "state": "Massachusetts",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-06-08",
    "article_sentence": "MILFORD, Mass., June 8, 2026 /PRNewswire/ - 55th International Symposium on High Performance Liquid Phase Separations and Related Techniques - Waters Corporation (NYSE: WAT) today announced the launch of the BioResolve(TM) Peptide and GTxResolve(TM) Lipid Phenyl-Hexyl+ and C18+ Columns, a first-of-its-kind reversed-phase (RP) column platform designed to tackle a persistent biopharmaceutical challenge: reliably separating structurally and chemically similar impurities in GLP-1 peptides, insulin, and lipid nanoparticles (LNPs) to support the development of safe, effective drug products."
  }
}

curl https://signals.autobound.ai/v1/signals/fdc7d4c3-5a8e-44cb-8bb6-2ea9821d38e6 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"waters.com","limit":20}'